CL-AR-397

N/A

Report date: 2023/10/17 14:13:23
NME

Base Information

Drug NameCL-AR-397
Drug Alias NameCL-AR-397
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen receptor splice variant 7 degradersAndrogen Receptor degraders
TargetsAndrogen receptor splice variant 7Androgen Receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesColoma Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesColoma Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A